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Abstract 
Hypoxia-inducible factor 1 (HIF-1) is a basic helix-loop-helix transcription factor that when induced 
regulates the expression of many genes involved in cytoprotective stimuli, which attenuates 
apoptosis and improves survival.. Increased expression of HIF-1α gene (HIF1A) has been found in 
several carcinomas, including ovarian cancer. Ovarian cancers are generally refractory to platinum-
based chemotherapy. Despite the large number of studies, molecular events that govern the 
emergence of aggressive therapy-resistant cells after chemotherapy are poorly defined. Genomic 
instabilities, such as copy number variation(CNV), may play an important role in chemoresistance 
and have been implicated in many complex diseases, like cancer.. We analyzed CNV data that is 
publically available through the Cancer Genome Atlas and others. Of particular interest was the 
transcription factor HIF1A which plays an integral role in oxidative stress response such as those 
induced by chemotherapy reagents. The present study provides evidence for the rare escape of 
tumor cells from drug-induced cell death by entering a non-cycling senescent state. We report the 
adaptive response of human ovarian surface epithelium cells to CoCl2, a chemical hypoxia-
mimicking agent resulting in a senescent-like state of chemoresistant cells. The effect of the 
treatment was evaluated on CNV of HIF-1α gene expression, cell proliferation, survival, and tumor 
invasiveness. We show here that CNV duplication events of HIF1α results in an oxidative stress 
response in cells leading to chemoresistance through the induction of cellular senescence. 
Understanding the molecular events associated with chemoresistance will ultimately lead to better 
patient treatment and outcomes. 
Note: This abstract was not presented at the meeting. 
 
